Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Sep 1;21(17):6933-9.
doi: 10.1523/JNEUROSCI.21-17-06933.2001.

Nociceptor sensitization by extracellular signal-regulated kinases

K O Aley  1 , A Martin, T McMahon, J Mok, J D Levine, R O Messing
Affiliations

Nociceptor sensitization by extracellular signal-regulated kinases

K O Aley et al. J Neurosci. .

Abstract

Inflammatory pain, characterized by a decrease in mechanical nociceptive threshold (hyperalgesia), arises through actions of inflammatory mediators, many of which sensitize primary afferent nociceptors via G-protein-coupled receptors. Two signaling pathways, one involving protein kinase A (PKA) and one involving the epsilon isozyme of protein kinase C (PKCepsilon), have been implicated in primary afferent nociceptor sensitization. Here we describe a third, independent pathway that involves activation of extracellular signal-regulated kinases (ERKs) 1 and 2. Epinephrine, which induces hyperalgesia by direct action at beta(2)-adrenergic receptors on primary afferent nociceptors, stimulated phosphorylation of ERK1/2 in cultured rat dorsal root ganglion cells. This was inhibited by a beta(2)-adrenergic receptor blocker and by an inhibitor of mitogen and extracellular signal-regulated kinase kinase (MEK), which phosphorylates and activates ERK1/2. Inhibitors of G(i/o)-proteins, Ras farnesyltransferases, and MEK decreased epinephrine-induced hyper-algesia. In a similar manner, phosphorylation of ERK1/2 was also decreased by these inhibitors. Local injection of dominant active MEK produced hyperalgesia that was unaffected by PKA or PKCepsilon inhibitors. Conversely, hyperalgesia produced by agents that activate PKA or PKCepsilon was unaffected by MEK inhibitors. We conclude that a Ras-MEK-ERK1/2 cascade acts independent of PKA or PKCepsilon as a novel signaling pathway for the production of inflammatory pain. This pathway may present a target for a new class of analgesic agents.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Epinephrine stimulates ERK1/2 phosphorylation in DRG neurons. A, ERK1/2 immunoreactivity present in cell bodies of neurons in freshly isolated DRG. The top shows incubation with anti-ERK1/2, whereas the bottom shows loss of immunoreactivity after preincubation of antibody with excess of peptide antigen. Scale bar, 100 μm. B, DRG cultures were treated with epinephrine for the indicated times and then processed for analysis of phospho-ERK1/2 immunoreactivity by Western analysis. Some cells were treated instead with 50 ng/ml NGF for 5 min as a positive control. Blots were then stripped and probed with anti phospho-ERK1/2 antibody. Representative Western blot demonstrating NGF and epinephrine stimulation of ERK1/2 phosphorylation.C, Mean ± SE values (n = 7–23) for phospho-ERK1/2 immunoreactivity normalized to total ERK1/2 immunoreactivity. *p < 0.05 by ANOVA and Dunnett's multiple comparison test. D, Representative Western blot showing concentration dependence of epinephrine-induced ERK1/2 phosphorylation.
Fig. 2.
Fig. 2.
Epinephrine-induced phosphorylation of ERK1 (gray bars) and ERK2 (black bars) is reduced by inhibitors of β2-adrenergic receptors and MEK and is independent of PKA and PKCε. A, DRG cultures were treated with 1 μm epinephrine (Epi; n = 9) for 5 min in the absence or presence of (A) ICI 118,551 (ICI; 100 nm; n = 7) or U0126 (U; 10 μm; n = 2). B, Cultures were treated with 1 μmepinephrine (Epi; n = 11) for 5 min in the absence or presence of H89 (1 μm;n = 5) or calphostin C (Cal; 1 μm; n = 7). C, DRGs cultured from PKCε wild-type (WT) or knock-out (KO) mice were treated with 1 μmepinephrine for 5 min (n = 3). Data are mean ± SE values. *p < 0.05 compared with phospho-ERK1 in epinephrine-treated cells; **p < 0.05 compared with phospho-ERK2 measured in epinephrine-treated cells (one-way ANOVA and Tukey's multiple comparison test).
Fig. 3.
Fig. 3.
Epinephrine-induced hyperalgesia is mediated by MEK, independent of PKA and PKCε. The mean ± SE baseline threshold before drug administration was 108.0 ± 0.5 gm (n = 162). A, Rats were treated intradermally with epinephrine (Epi; 100 ng;n = 12), UO126 (U; 1 μg;n = 6), UO126 plus epinephrine (U/Epi; n = 12), PD98059 (PD; 1 μg; n = 6), and PD98059 plus epinephrine (PD/Epi; n = 12).B, Rats were treated intradermally with PGE2(100 ng; n = 6), UO126 plus PGE2(U/PGE2; n = 6), and PD98059 plus PGE2(PD/PGE2; n = 6).C, Rats were treated intradermally with the PKCε agonist ψεRACK (ψεR; 1 μg;n = 6), UO126 plus PKCε agonist (U/ψεR; n = 6), and PD98059 plus PKCε agonist (PD/ψεR; n = 6).D, Rats were treated intradermally with active MEK (MEK+; 0.5 U; n = 12), inactive MEK (MEK−; 1 μg; n = 6), PKCε inhibitor (εV1–2; 1 μg; n = 6), PKCε inhibitor plus active MEK (εV1–2/MEK+;n = 6), WIPTIDE (WIP; 1 μg;n = 6), and WIPTIDE plus active MEK (WIP/MEK+; n = 6). *p < 0.05 by one-way ANOVA and Newman–Keuls test.
Fig. 4.
Fig. 4.
Epinephrine-induced mechanical hyperalgesia is mediated by a Gi/o-protein and Ras. The mean ± SE baseline threshold before drug administration was 108.0 ± 0.5 gm (n = 162). A, Rats were treated intradermally with epinephrine (Epi; 100 ng;n = 12), pertussis toxin (PTX; 1 μg; n = 6), or pertussis toxin plus epinephrine (PTX/Epi; n = 8). B, Rats were treated intradermally with epinephrine (Epi; 100 ng; n = 12), perillic acid (PER; 1 μg; n = 6), or perillic acid plus epinephrine (PER/Epi; n = 8). C, Rats were treated intradermally with epinephrine (Epi; 100 ng; n = 12), farnesyltransferase inhibitor I (FT; 1 μg; n = 6), or farnesyltransferase inhibitor I plus epinephrine (FT/Epi; n = 8). *p < 0.05 by one-way ANOVA and Newman–Keuls test.
Fig. 5.
Fig. 5.
Pertussis toxin (PTX) and farnesyltransferase inhibitor I (FT) inhibit epinephrine-induced ERK1/2 phosphorylation in DRG cultures. DRG cultures were treated with 100 nm pertussis toxin or 1 μm FTase I for 16 hr and then with or without 1 μm epinephrine (Epi) as indicated. Data are mean ± SE values from five to eight experiments. *p < 0.05 compared with phospho-ERK1 in epinephrine-treated cells; **p < 0.05 compared with phospho-ERK2 measured in epinephrine-treated cells (one-way ANOVA and Newman–Keuls test).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adams JP, Anderson AE, Varga AW, Dineley KT, Cook RG, Pfaffinger PJ, Sweatt JD. The A-type potassium channel Kv4.2 is a substrate for the mitogen-activated protein kinase ERK. J Neurochem. 2000;75:2277–2287. - PubMed
    1. Aley KO, Levine JD. Role of protein kinase A in the maintenance of inflammatory pain. J Neurosci. 1999;19:2181–2186. - PMC - PubMed
    1. Aley KO, McCarter G, Levine JD. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci. 1998;18:7008–7014. - PMC - PubMed
    1. Aley KO, Messing RO, Mochly-Rosen D, Levine JD. Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci. 2000;20:4680–4685. - PMC - PubMed
    1. Bailey CH, Kaang B-K, Chen M, Martin KC, Lim C-S, Casadio A, Kandel ER. Mutation in the phosphorylation sites of MAP kinase blocks learning-related internalization of apCAM in Aplysia sensory neurons. Neuron. 1997;18:913–924. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources